VIDEO: Pay attention to CV risk in young adults, measure Lp(a)

ByScott Buzby

ByErin D. Michos, MD, MHS, FACC, FAHA, FASE, FASPC

Fact checked byErik Swain

BOSTON — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, discusses her presentation at the Cardiometabolic Health Congress, “Primary Prevention of CVD: The Sooner the Better?”

“I would urge the audience to not ignore CV risk in young adults and to measure lipoprotein(a) in all adults at least once in a lifetime. It'll also identify younger adults who may have higher lifetime risk,” Michos said. “Think about treating sooner and not wait until someone is already at very high 10-year risk or already has established plaque or atherosclerotic CVD.”

Watch the video for more.

Reference:

Michos ED. Session IV: Dyslipidemia/Atherosclerosis/Thrombosis. Presented at: Cardiometabolic Health Congress; Oct. 17-19, 2024; Boston.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures: Michos reports consulting and/or serving on advisory boards for AstraZeneca, Amgen, Boehringer Ingelheim, Edwards Lifesciences, Esperion, Medtronic, Merck, Novartis, Novo Nordisk and Pfizer.

Cardiometabolic Health Congress

Read more

VIDEO: Pay attention to CV risk in young adults, measure Lp(a)

Reference:

Related Content